[1]Nakahara,Kenji;Mitsuoka,Yasunori;Kasuya,Satoshi;Yamamoto,Takahiko;Yamamoto,Shiho;Ito,Hisanori;Kido,Yasuto;Kusakabe,Ken-ichi[EuropeanJournalofMedicinalChemistry,2021,vol.216]
1353953-70-4 | Cyclopropyl-[6-(4-MethylaMino-piperidin-1-yl)-pyriMidin-4-yl]-aMine hydrochloride | AA009I1L | MFCD21098684
1256358-92-5 | 5-Bromoindole-2-boronic acid, pinacol ester | AA009IMQ | MFCD11858360
1310350-99-2 | 4-Chloro-1-(difluoromethyl)-1H-pyrazole-3-carboxylic acid | AA009JB5 | MFCD03420212
134167-07-0 | (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methoxypropanoate | AA009JUG | MFCD18837831
1035229-33-4 | 5-(Benzyloxy)-8-(2-chloroacetyl)-2h-benzo[b][1,4]oxazin-3(4h)-one | AA009KMK | MFCD22575152
1030829-65-2 | 1-(3-Chloro-2-fluorophenyl)biguanide, HCl | AA009MFX | MFCD03094446
1185303-27-8 | 5,6-Dimethylthieno[2,3-d]thiazol-2-amine hydrochloride | AA009OBK | MFCD08447196
103-98-0 | N-(4-hydroxyphenyl)dodecanamide | AA009QRX | MFCD00020147
109574-84-7 | 2-Iodo-1-(perfluorohexyl)octane | AA009TO2 | MFCD16606065
1213364-80-7 | (1S)-5-CHLORO-1,2,3,4-TETRAHYDRONAPHTHYLAMINE | AA009VKK | MFCD07373995
